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Abstract
Background Colorectal endoscopic submucosal dissection (ESD) is an effective but challenging procedure. To facilitate 
ESD, several methods that apply traction are available; however, the optimal one remains to be established. The aim of this 
study was to evaluate the feasibility and safety of the double-endoscope assisted ESD (DEA-ESD) by improving traction to 
treat complex colorectal lesions.
Methods Naïve or previously treated lesions in the rectum and sigmoid colon were included. A grasping forceps advanced 
through a small-caliber endoscope (GIF-XP190N, Olympus Medical Systems, Tokyo, Japan, 5.4 mm outer diameter) was 
used to apply traction to the mucosal flap. Lesions were deemed complex when they exceeded a total of nine points on the 
SMSA scoring system (size, morphology, site, and access) and recurrent when they were previously treated with endoscopic 
mucosal resection (EMR). Outcome measures included procedural success, total procedure time, complications, and recur-
rence rate at 3-month follow-up.
Results Nine patients (mean age 62.3 ± 14.5 years) were included; five had rectal and four had tumors in the sigmoid colon. 
The median SMSA score was 14 (SMSA Level IV—complex polyp), while three patients were pre-treated with EMR. DEA-
ESD was technically feasible in all cases. En bloc resection and R0 resection rates were 100%, respectively, with a mean 
procedure time of 128.4 ± 54.1 min. No immediate or delayed complications occurred.
Conclusions DEA-ESD is a feasible and safe method for treating complex or recurrent tumors in the rectum and distal colon.
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Introduction
Endoscopic submucosal dissection (ESD) is a sophisticated 
resection technique for the treatment of precancerous and 
early cancerous lesions in the gastrointestinal tract (GIT) [1]. 
During ESD, endoscopic dissection of the submucosal layer 
is a key step towards successful en bloc and R0 resection 
[2]. Nevertheless, in many cases, it proves to be difficult 
to access the submucosal layer, especially in large, flat, or 
recurrent lesions following endoscopic mucosal resection 
(EMR) [3]. In such cases, the submucosal space is either 
narrow or fibrotic with difficult visualization of the cutting 
plane and increased risk of complications, i.e., bleeding or 
perforation. Widening of the submucosal space facilitating 
visualization and dissection of the submucosal layer dur-
ing ESD can be achieved by traction, offering the poten-
tial to improve the speed and ease of submucosal dissec-
tion. Various advanced technology endoscopes, innovative 
devices i.e., DiLumen Endolumenal Interventional Platform 
(Lumendi Ltd., High Wycombe, UK) or ORISE TRS (Bos-
ton Scientific Corp, Marlborough, MA, USA), as well as 
techniques, i.e., clip-with-line or gravity, have been imple-
mented in an effort to optimize traction during ESD and ulti-
mately enhance the procedure`s performance [4]. Double-
endoscope assisted ESD (DEA-ESD) achieves traction using 
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two separate endoscopes inserted into the lumen parallel to 
each other. A grasping forceps advanced through the second-
ary endoscope is used to tug on the mucosal flap, thereby 
maintaining adequate view of the submucosal layer, while 
ESD is performed through the primary endoscope. Although 
this method has been proven to be efficacious in the treat-
ment of upper gastrointestinal lesions [5], data regarding its 
efficacy on colorectal lesions ESD are scarce [6]. Moreover, 
it remains to be elucidated whether this method could be 
advantageous in the resection of difficult colorectal polyps. 
We conducted a pilot study aiming to evaluate the feasibility 




This study was conducted from February to July 2019 in 
the Department of Gastroenterology, University Clinic 
of Augsburg, Germany. Consecutive patients aged older 
than 18 years were included when en bloc resection with 
other resection techniques, particularly EMR (lesions 
size > 20 mm, recurrence after EMR), was not possible or 
when malignancy was macroscopically suspected (depressed 
morphology, pit pattern V). Data were collected prospec-
tively and analyzed retrospectively. All patients provided 
written informed consent. The study was conducted in 
accordance with the ethical principles of the Declaration 
of Helsinki, in compliance with good clinical practice and 
according to local regulations.
Study measures and definitions
The primary outcome of the study was the procedural suc-
cess of DEA-ESD (R0 resection rate, recurrence rate) [7]. 
Other outcome measures included procedure time (time for 
total ESD procedure), en bloc resection (defined as resection 
of the targeted area in one piece [8]), R0 resection (defined 
as histopathologically proven tumor-free lateral and vertical 
margins without lymphatic or vascular involvement and sub-
mucosal invasion depth < 1000 μm and no poorly differenti-
ated histology [9]), resection speed (estimated in minutes/
cm2, as previously reported [2]), and safety (complication 
rate as previously defined [10]). A lesion was deemed com-
plex when it exceeded a total of nine points on the SMSA 
scoring system (size, morphology, site, and access) [11] and 
recurrent if it has been treated previously by EMR. Lesion 
size was calculated as the surface of an ellipse using the 
long and the short diameter of the resection specimen and is 
presented in  cm2 [2].
Diagnostic work‑up
All lesions were initially assessed with white light as well 
as narrow band imaging and classified according to the 
Paris, laterally spreading tumors (LST) and Japan NBI 
Expert Team (JNET) classifications, respectively. A SMSA 
score was estimated for each lesion [11].
Double‑endoscope ESD procedure (DEA—ESD): 
Video 1
For all procedures, a video gastroscope (GIF-HQ190, 
Olympus Medical Systems, Tokyo, Japan) with a trans-
parent cap (D-201–11804, Olympus) was used. Sedation 
included midazolam and propofol administered by a sec-
ond physician, under constant cardiorespiratory monitor-
ing. A mixed solution of saline, epinephrine (1:100.000), 
glycerol (10%), and indigo-carmine was used for the sub-
mucosal injection, while in cases with severe fibrosis, 
hyaluronic acid (Sigmavisc™, Hyaltech Ltd., Livingston, 
UK) was available. For all procedures, a hook knife (KD-
620LR; Olympus), an electrosurgical unit (VIO 300D elec-
trosurgical generator (ERBE Elektromedizin, Tübingen, 
Germany), and insufflation with carbon dioxide were used. 
ESD was performed in a standardized manner initially with 
injection, mucosal incision, and submucosal dissection at 
lesion’s distal margin in forward view. Thereafter, cir-
cumferential mucosal incision was completed and partial 
exfoliation using the primary endoscope was performed. 
Next, a smaller caliber endoscope (GIF-XP190N, Olympus 
Medical Systems, Tokyo, Japan, 5.4 mm outer diameter) 
using a second light source mounted on a complementary 
endoscopic tower and operated by a second physician was 
inserted into the lumen parallel to the primary endoscope. 
The second physician was positioned to the right side of 
the primary physician. The second endoscopic tower was 
positioned beside the primary tower, so that both physi-
cians had a clear view of both monitor screens. It was 
usually helpful to insert the primary endoscope first after 
which the second endoscope was advanced and not vice-
versa. This enabled the better positioning of both endo-
scopes. Friction was sometimes experienced between the 
scopes, especially for more proximally located lesions. 
Generous amounts of lubricants were always necessary 
and, sometimes, silicon spray was helpful in reducing 
friction between the scopes. A grasping forceps (Raptor® 
grasping device—mini, US endoscopy, Mentor OH, USA) 
was advanced through the working channel of the smaller 
caliber endoscope allowing the lesion to be grasped 
along its margin (Fig. 1). Each endoscope was maneu-
vered and controlled by the respective physician. The 
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grasping forceps was controlled by the second physician 
and in some cases by a second assisting endoscopy nurse. 
Lesions could be grasped at the endoscopist`s discretion, 
either proximally in the reverse-viewing mode or distally 
in the forward-viewing mode. The thinner endoscope 
could move independently and the grasping forceps could 
be also inserted or retracted on demand. Traction direc-
tion was easy to control due to scope`s flexibility, while 
optimal visualization of the submucosal plane achieved 
by tissue traction resulted in safer dissection. The second 
endoscope was used intermittently during the procedure, 
and traction could be applied even after having completed 
the incision, and was withdrawn after sufficient entrance 
into the submucosal layer was achieved. For lesions with 
fibrotic and non-lifting mucosa, the thinner endoscope was 
inserted on demand, especially when areas of non-lifting 
were encountered. However, during dissection, the second 
endoscope had to be kept as motionless as possible so as 
not to convey movements of the second endoscope onto 
the movements of the primary endoscope. All ESD proce-
dures were performed by two ESD experts (HM and AE).
Histopathologic evaluation and follow‑up
After each ESD, the specimen was fixed on cork with nee-
dles and fixed in 10% formalin. Specimen size was meas-
ured and sent for histopathological assessment. Lesions 
were classified as adenoma with either low-grade or high-
grade intraepithelial neoplasia (LGIEN, HGIEN). R0 or 
R1 was described for the vertical margin (VM) and hori-
zontal margin (HM). Follow-up with repeat endoscopy was 
scheduled at 3 months.
Statistical analysis
Quantitative data were expressed as mean (standard devia-
tion [SD]) or median with range and qualitative data, as 
frequencies and percentages, respectively. Statistical Pack-
age for the Social Sciences (SPSS) v.24 (IBM, Chicago, 
IL, USA) was used for the analysis.
Fig. 1  a, b Endoscopic submucosal dissection of a laterally spread-
ing tumor in the rectum. c Traction applied to the lesion with use of a 
grasping forceps, introduced through the working channel of a small-
caliber endoscope. d Resection specimen—histopathology assess-
ment showed tubular adenoma with high-grade intraepithelial neopla-
sia resected R0
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Results
A total of nine DEA-ESD procedures were performed for 
colorectal lesions. All procedures were technically feasi-
ble and none was discontinued during implementation of 
the method. Patient, tumor characteristics, and DEA-ESD 
outcomes are summarized in Table 1. In five patients, the 
tumor was located in the rectum, while in other cases, the 
lesions were in the sigmoid colon. Paris type 0–IIa + Is 
(granular type LST nodular mixed type) was the most fre-
quent lesion type (55.6%). All lesions scored a minimum 
of 12 points (median 14, range 12–16) in the SMSA scor-
ing system, and, therefore, were level IV (complex polyp), 
while pre-ESD endoscopic treatment (EMR) had been per-
formed in three patients. Non-lifting sign was not evident 
in any lesion. DEA-ESD was technically feasible in all 
cases (n = 9, 100%). Mean tumor size was 64.02 cm2 (SD 
31.2) with a mean procedure time of 128.4 min (SD 54.1) 
and mean resection speed of 2.26 min/cm2 (SD 1.06). En 
bloc and complete resection rates were 100%, respec-
tively. No immediate or delayed complications related to 
the procedure occurred, while on follow-up endoscopy at 
3 months, residual/recurrent tumor was not detected in any 
of the patients (n = 0, 0.0%).
Discussion
DEA-ESD has been proposed as a feasible method that could 
improve traction and ultimately improve ESD performance. 
To the best of our knowledge, this is the first study to demon-
strate feasibility of the DEA-ESD for resection of recurrent 
and pre-defined complex lesions in the rectum and sigmoid 
colon in a large-volume European center.
Rectal ESD procedures may not be particularly demand-
ing due to easy accessibility, straight scope, and the rela-
tively thick rectal wall. However, the level of difficulty rises 
significantly for larger lesions spreading across folds with 
poor accessibility such as those located in the proximal rec-
tum or distal sigmoid. In the absence of a validated scoring 
system, we used the SMSA system for stratifying the diffi-
culty of resection. Although its ability to effectively predict 
colorectal ESD clinical outcomes (excessive duration of the 
procedure, percentage of piecemeal resections, aborted pro-
cedures, and complications) has been recently challenged, 
Table 1  Patient and lesion 
characteristics and outcomes of 
treatment
SD standard deviation, ASA American Association of Anesthesiologists, EMR endoscopic mucosal resec-
tion, JNET Japan NBI Expert Team, LGIEN low-grade intraepithelial neoplasia, HGIEN high-grade 
intraepithelial neoplasia, SMSA size, morphology, site, and access score, ESD endoscopic submucosal dis-
section
a Including delayed bleeding, perforation, stenosis, and pain CTCAE, Common Terminology Criteria of 
Adverse Events (version 4.0)
Patient characteristics
Age, mean (SD), years 62.3 (14.5)
Sex, male/female, n (%) 6 (66.7)/3 (33.3)
ASA grade I/II, n (%) 3 (33.3)/6 (66.7)
Lesion characteristics
 Location: rectum/ sigmoid colon, n (%) 5 (55.6)/4 (44.4)
 Treatment-naïve lesion, n (%) 6 (66.7)
 Pretreated lesion (previous EMR), n (%) 3 (33.3)
 Paris classification: 0–Is/0–IIa/0–IIa + Is/0–IIa + IIc, n (%) 0/3 (33.3)/5 (55.6)/1 (11.1)
 JNET classification: type 2A/Type 2B, n (%) 7 (77.8)/2 (22.2)
 Surface pattern: granular/non granular/granular mixed 0/3 (33.3)/6 (66.7)
 SMSA scoring system: median (range) 14 (12—16)
 Lesion size: mean (SD),  cm2 64.02 (31.2)
 Histology: LGIEN/HGIEN, n (%) 5 (55.6)/4 (44.4)
Outcomes of treatment
 Successful rate of DEA-ESD, n (%) 9 (100.0)
 Procedure time: mean (SD), minutes 128.4 (54.1)
 Resection speed: mean (SD), minutes/cm2 2.26 (1.06)
 Resection: En bloc/piecemeal, n (%) 9 (100.0)/0 (0.0)
 R0 resection: R0/R1–Rx, n (%) 9 (100.0)/0 (0.0)
 Complications (CTCAE grade)a, n (%) 0 (0.0)
 Recurrence at 3 months after index ESD, n (%) 0 (0.0)
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whether this also extends to other outcomes, i.e., R0 resec-
tion remains to be seen [12]. Furthermore, recurrent lesions 
with fibrotic submucosal tissue will show little or no lifting 
during submucosal injection making the dissection of the 
submucosal layer extremely demanding. In this regard, our 
findings support the notion that DEA-ESD can be a use-
ful adjunct tool when treating complex (SMSA score > 9) 
lesions, as it was successfully applied in all cases. Traction 
provided was easily maneuverable due to the thinner scope`s 
increased flexibility that allowed accurate identification of 
the submucosal plane increasing the efficiency of dissection 
while, at the same time, reducing the risk of complications.
One might dispute the method`s utility given the fact that 
its applicability is limited to the distal colon and rectum 
while at the same time less resource-consuming (i.e., no 
need for a second endoscopist) and cost-effective methods 
to apply traction, i.e., clip-with-line or gravity are available. 
Still, for such lesions, gravity or tissue traction may not be 
sufficient. Moreover, expertise level among endoscopists 
who perform ESD may significantly vary. On this point, 
DEA-ESD could be potentially helpful for endoscopists 
with a slow learning curve, which, indeed, seems to be the 
case in Western countries [10]. An additional advantage of 
the technique as compared to other traction methods would 
be the possibility to apply it at any time during the ESD. 
Moreover, in recent years, several novel devices that provide 
and facilitate tissue retraction in special cases have emerged. 
Among them, a double balloon platform and sheath (DiLu-
men Endolumenal Interventional Platform; Lumendi Ltd., 
High Wycombe, UK) that facilitates exposure of difficult-
to-access, due to poor scope maneuverability and loop pres-
ence, lesions [13], and another system (ORISE TRS; Bos-
ton Scientific Corp, Marlborough, MA, USA) that expedites 
colorectal ESD in cases of significant fibrosis from previous 
tattooing [14]. Nonetheless, these pioneer systems have not 
yet been extensively studied, concerns about their maneu-
verability have been raised, while the additional financial 
burden from their use cannot be underestimated.
A number of studies have investigated the applicability of 
DEA-ESD for GIT tumors (Table 2 summarizes data from 
all available studies evaluating exclusively the use of a sec-
ond endoscope to deliver traction during ESD performance 
in various gastrointestinal tract sites [5, 6, 15–18]). How-
ever, the majority of them refer to upper GIT lesions. To 
date, only a single study compared ESD outcomes regard-
ing colorectal laterally spreading tumors (LST) in 21 cases 
of DEA-ESD and 16 cases of standard ESD [6]. En bloc 
resection was similar in the two methods [21 (100%) vs. 
16 (100%), p = n.s]. Although procedure time was shorter 
with DEA-ESD, the difference did not reach significance 
(96 ± 53 min vs. 116 ± 74 min, p = n.s). It is noteworthy that 
examinations were performed by ESD experts in a Japanese 
center; this limits generalizability of the results in every-day 
clinical practice. Higuchi et al. [15] in a retrospective study 
used a switchable light source between the two endoscopes 
for treating early gastric cancer. This modification improved 
the cutting rate into specimen (7% vs. 35%, p = 0.01), while 
no serious adverse events was noted. However, it should be 
underlined that all comparisons were made with historical 
control data, Ahn et al. [5] found that the main outcomes of 
DEA-ESD and standard technique used for gastric lesions 
did not differ. Despite its good design, the low number of 
patients (n = 51) and lack of experience by endoscopists per-
forming the ESD are points that attracted criticism. Ogata 
et al. [16] enrolled more participants (n = 122), highlighting 
the safety and efficacy of a double-endoscopic intraluminal 
operation for precancerous gastric lesions. Finally, results 
from the most recent iterations show a similar duration and 
complication rate for DEA-ESD and standard technique 
when treating upper GIT lesions [17, 18]. Data from those 
studies show that the method is “operator friendly”, improv-
ing accessibility to the sub-mucosa, while reducing the risk 
of complications. However, interference between the two 
endoscopes and need for two light sources, endoscopes and 
physicians, seems to undermine its role. Moreover, data 
evaluating the method’s efficacy based on the anatomical 
site of the lesion or the endoscopist’s level of expertise are 
lacking. In the current study, we went a step further and 
evaluated DEA-ESD on tumors with a high SMSA score 
or recurrent lesions, showing excellent en bloc and cura-
tive resection rates with no recurrence. Of note, we did not 
find any limitation regarding the maneuverability of the two 
endoscopes in such large lesions; perhaps, the small diam-
eter of the second scope played a significant part in this 
preventing friction between the scopes. Most importantly, 
no complications occurred, even though the expected risk of 
perforation and bleeding is high. Although our results sug-
gest that DEA-ESD is feasible and safe, the small number of 
patients enrolled is the study’s main limitation. Moreover, all 
cases were performed with the DEA- ESD method, and thus, 
no comparison with the standard ESD technique in terms 
of procedure parameters, i.e., resection speed, is possible.
Conclusions
DEA-ESD is a feasible and safe method for treating com-
plex or recurrent tumors in the rectum and distal colon.
DEA-ESD can be considered by European endoscopists 
as an option to enhance the accessibility of the sub-mucosa 
as well as increase the efficiency of submucosal dissec-
tion of complex colorectal polyps. Further studies are war-
ranted to establish the value of this method compared to 
other traction methods available.
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Table 2  Comparison of current study results with the literature
RCT randomized control trial, Pts patients, ESD endoscopic submucosal dissection, SMSA site, morphology, size, access scoring system, EMR 
endoscopic mucosal resection, NA not available
Author refer-
ences
Uraoka et al. [6] Ahn et al. [5] Higuchi et al. 
[15]
Ogata et al. [16] Colak et al. [17] Sohda et al. [18] Current study
Country Japan Korea Japan Japan Turkey Japan Germany






























37/21/16 51/25/26 57/30/27 122/122/0 22/22/0 111/51/60 9/9/0
Endoscopist 
expertise level
1 expert 2 nonexperts Experts NA NA Experts 2 experts
ESD location, n Rectum: 14, 
Sigmoid: 7
Stomach, 51 Stomach, 30 Stomach, 122 Stomach, 22 Esophagus, 111 Rectum 5, 
Sigmoid 4
Tumor size 
(mean ± SD; 
mm)









NA NA NA NA NA NA 14 (12—16)
Pretreated 
(EMR), n (%)
NA NA NA NA NA NA 3 (33.3)
En bloc resec-
tion, n (%)
21 (100) 26 (100) 30 (100) 119 (97.5) NA 46 (90.0) 9 (100)
Procedure time 
(mean ± SD; 
minutes)






114 ± 54.5 128.4 ± 54.1
Complications, 
n (%)
0 (0.0) 2 (7.7) 9 (30) 7 (6.0) NA 1 (1.96) 0 (0.0)
Recurrence, n 
(%)
NA NA NA 2 (1.6) NA NA 0 (0.0)
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